These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9721727)

  • 1. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
    Hawes BE; Fried S; Yao X; Weig B; Graziano MP
    J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
    Mandyam CD; Thakker DR; Standifer KM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
    Mandyam CD; Thakker DR; Christensen JL; Standifer KM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
    Ozsoy HZ; Thakker DR; Standifer KM
    Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
    Thakker DR; Standifer KM
    Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nociceptin/orphanin FQ activates mitogen-activated protein kinase in Chinese hamster ovary cells expressing opioid receptor-like receptor.
    Lou LG; Zhang Z; Ma L; Pei G
    J Neurochem; 1998 Mar; 70(3):1316-22. PubMed ID: 9489755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
    Wang Q; Traynor JR
    Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
    Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
    J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ activates protein kinase C, and this effect is mediated through phospholipase C/Ca2+ pathway.
    Lou LG; Ma L; Pei G
    Biochem Biophys Res Commun; 1997 Nov; 240(2):304-8. PubMed ID: 9388473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitarius.
    Endoh T
    Br J Pharmacol; 2006 Feb; 147(4):391-401. PubMed ID: 16402042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of c-Jun N-terminal kinase by the ORL(1) receptor through multiple G proteins.
    Chan AS; Wong YH
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1094-100. PubMed ID: 11082445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphanin FQ-ORL-1 regulation of reproduction and reproductive behavior in the female.
    Sinchak K; Dalhousay L; Sanathara N
    Vitam Horm; 2015; 97():187-221. PubMed ID: 25677773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.
    Butour JL; Moisand C; Mazarguil H; Mollereau C; Meunier JC
    Eur J Pharmacol; 1997 Feb; 321(1):97-103. PubMed ID: 9083791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
    Chiou LC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
    Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
    Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
    Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
    Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation.
    Hawes BE; van Biesen T; Koch WJ; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 1995 Jul; 270(29):17148-53. PubMed ID: 7615510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits.
    Belcheva MM; Vogel Z; Ignatova E; Avidor-Reiss T; Zippel R; Levy R; Young EC; Barg J; Coscia CJ
    J Neurochem; 1998 Feb; 70(2):635-45. PubMed ID: 9453557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin/orphanin FQ stimulates extracellular acidification and desensitization of the response involves protein kinase C.
    Pei G; Ling K; Pu L; Cunningham MD; Ma L
    FEBS Lett; 1997 Jul; 412(1):253-6. PubMed ID: 9257731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways.
    Hawes BE; Kil E; Green B; O'Neill K; Fried S; Graziano MP
    Endocrinology; 2000 Dec; 141(12):4524-32. PubMed ID: 11108264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.